SCHEMBL10202903

SCHEMBL10202903

CB(O)N1CCC(C)C(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14651113 0.83 ALDH1A1 (0.32) —
SCHEMBL17464288 0.77 — —
SCHEMBL413824 0.76 NOTUM (0.41) —
SCHEMBL12592377 0.73 SLC6A2 (0.49) —
SCHEMBL14371524 0.73 SLC6A2 (0.49) —
SCHEMBL12592372 0.73 SLC6A2 (0.49) —
SCHEMBL13473846 0.73 SLC6A2 (0.49) —
SCHEMBL12904166 0.73 ALDH1A1 (0.43) —
SCHEMBL25225141 0.72 ALDH1A1 (0.33) —
SCHEMBL28798049 0.72 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160024121-A1 BETA-LACTAMASE INHIBITORS VenatoRx Pharmaceuticals, Inc. 2016-01-28 — — US disclosed
US-20120035214-A1 RENIN INHIBITORS MERCK CANADA INC. (CA) 2012-02-09 — — US disclosed
Send feedback